The content on this page is designed for . Check courses designed for Canada (EN)
This course has expired. View available courses.
Respirology
New Avenues for Promoting Control in Chronic Disease: Opportunities in Asthma, COPD, and Diabetes – Ordre des pharmaciens du Québec (OPQ)
Upon completion of this program, participants will be able to:
Asthma Module
- Assess current asthma control.
- Make recommendations to adjust therapy for optimal current and future control of asthma.
- Counsel patients about the importance of adhering to therapy to promote future control and prevent exacerbations.
COPD Module
- Make recommendations to optimize management of COPD using current approaches.
- Make recommendations to help patients with COPD prevent future acute exacerbations.
- Counsel patients about medication adherence using the written action plan, for promotion of disease control.
Diabetes Module
- Describe the role of the new class of SGLT2i agents in the management of type 2 diabetes for health-promotion.
- Identify patients for whom SGLT2i therapy is appropriate, based on patient and agent characteristics.
- Counsel patients to support adherence, safety, and efficacy when initiating an SGLT2i.
DURATION
PROFESSION
# OF CREDITS
1.50
ACCREDITATION
EXPIRY DATE
1969-12-31
Upon completion of this program, participants will be able to:
Asthma Module
- Assess current asthma control.
- Make recommendations to adjust therapy for optimal current and future control of asthma.
- Counsel patients about the importance of adhering to therapy to promote future control and prevent exacerbations.
COPD Module
- Make recommendations to optimize management of COPD using current approaches.
- Make recommendations to help patients with COPD prevent future acute exacerbations.
- Counsel patients about medication adherence using the written action plan, for promotion of disease control.
Diabetes Module
- Describe the role of the new class of SGLT2i agents in the management of type 2 diabetes for health-promotion.
- Identify patients for whom SGLT2i therapy is appropriate, based on patient and agent characteristics.
- Counsel patients to support adherence, safety, and efficacy when initiating an SGLT2i.
Cost of course:
Free